PPT-Developing a surgical site infection bundle to improve patient outcomes

Felix W Tsai MD 1 Kathy Masters RD 2 Douglas Maposa MD 3 Lillian S Kao MD 4 Charles Monney MS 5 and Galit HolzmannPazgal MD 6 1 Department of Pediatric Surgery 3 Department of Anesthesia 4 Department of Surgery 6 Department of Pediatrics UTHSC 2 Department of Healthcare Improvement 5 Department of Infection Control Memorial Hermann Hospital. Activity C: ELC Prevention Collaboratives. S.I. Berríos-Torres, MD. Division of Healthcare Quality Promotion. Centers for Disease Control and Prevention. Draft - 12/21/09 --- Disclaimer: The findings and conclusions in this presentation are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.. Presented By:. Shelly Stalter, MSN, MBA, RN, RNFA, CNOR. Dawn Evans, MSN, RN, PHN, CPPS. Colleen Coots, BSN, RNFA, CNOR. Objectives. Relate the national costs and occurrence of total joint surgical site infections to Barton’s incidence rate. . Presented By:. Shelly Stalter, MSN, MBA, RN, RNFA, CNOR. Dawn Evans, MSN, RN, PHN, CPPS. Colleen Coots, BSN, RNFA, CNOR. Objectives. Relate the national costs and occurrence of total joint surgical site infections to Barton’s incidence rate. . Activity C: ELC Prevention Collaboratives. S.I. Berríos-Torres, MD. Division of Healthcare Quality Promotion. Centers for Disease Control and Prevention. Draft - 12/21/09 --- Disclaimer: The findings and conclusions in this presentation are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.. AHRQ Safety Program for Surgery. Implementation. . AHRQ Pub. No. 16(18)-0004-15-EF. December 2017. Learning Objectives. After this session, you will be able to–. Develop . an implementation plan for your . AHRQ Safety Program for . Surgery. Onboarding. AHRQ Pub No. . 16(18)-. 0004-15-EF. December. . 2017. Learning Objectives. After this session, you will be able . to—. Develop and implement a surgical site infection (SSI) reduction goal and prevention . Project Team Members. Stan Taylor, MD. UTSW Dermatology. Stacey Clark, RN, MBA. UTSW Ambulatory Administration. Anju Varghese, MPH, CIC. UTSW Ambulatory Infection Control. John . Morris. UTSW Organization Development. Costs more than $10 billion a year resulting in an additional 400,000 patient days in the hospital. Indicator of care quality. Associated with up to 3% of maternal mortality . Leading cause of serious complications after cesarean section with an incidence of 3-15% . Enumerate the factors responsible for surgical site infection. . Nosocomial Infection . An infection acquired in hospital by a patient who was admitted for a reason other than that infection .. Infections occurring for more than 48 hours after admission are usually considered nosocomial . Maureen Spencer, . M.Ed. , BSN, RN, CIC, FAPIC. Infection . Preventionist. Consultant. Boston, MA. www.7sbundle.com. www.workingtowardzero.com. Faculty Disclosure. Maureen P. Spencer, MEd, BSN, RN, . Updated Guidelines and Questions about Surveillance. Dale W. Bratzler, DO, MPH. Professor and Associate Dean, College of Public Health. Professor, College of Medicine. Chief Quality Officer – OU Physicians Group. Kaye KS, Sands K, Donahue JG, Chan KA, Fishman P, Platt R. Preoperative Drug Dispensing as Predictor of Surgical Site Infection. Emerg Infect Dis. 2001;7(1):57-65. https://doi.org/10.3201/eid0701.700057. Surveillance. Outline. This webinar will discuss:. the role of surveillance in preventing SSIs and improving outcomes for patients. implementing the surveillance process in DHBs. surveillance methodology; process and workflow. ). Dr. Adel Al-. Najjar. Consultant Urologist. Bacteria. Bacteria are very small (usually . single-cell) organisms.. They . are one . of the . first life forms to exist on Earth and have been around .